Factors Related to The Real Costs for Stroke Patients in The Hospitals, Yogyakarta City, Indonesia
Main Article Content
Abstract
Background: Stroke is a main cause of mortality and disability, resulting in severe, moderate, and mild impairments that need expensive medical care. This research aims to identify the variables affecting the actual expenses of treating stroke patients in Indonesian hospitals in the Yogyakarta region.
Method: This study was carried out using a cross-sectional design and an analytical observational technique based on variable instruments used to measure the real costs for stroke patients. The total population amounted to 416 respondents using the total sampling method. Inclusion criteria include national health insurance patients, first-attack ischemic stroke, onset less than 24 hours and non-referral. Retrospective data collection of inpatients was observed from October 1, 2021, to March 31, 2022, for six months. Research data secondary data sourced from medical records, International Financial Reporting Standard (IFRS), and hospital Technology Units. Analysis of statistical data using the Chi-square test.
Result: Age, gender, length of stays, inpatient classes, and hospital type have been identified as variables related to the real cost of stroke patients in the hospitals with a p-value < 0.05.
Conclusion: All variables examined in this study are connected to the expenses incurred by stroke victims in hospitals. However, several files of medical records cannot be identified in the study which means that other variables like comorbidities might also related to inpatient costs of stroke patients and need to be analysed for future study.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
How to Cite
References
1. Omote Y, Deguchi K, Tian F, Kawai H, Kurata T, Yamashita T, et al. Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol. Stroke. 2012;43(6):1639–46.
2. Organization WH. World health statistics 2015. Geneva: World Health Organization; 2015.
3. Chang KC, Tseng MC, Weng HH, Lin YH, Liou CW, Tan TY. Prediction of Length of Stay of First-Ever Ischemic Stroke. Stroke. 2002 Sep;33(11):2670–4.
4. Purbaningsih S, Wahyono D, Suparniati E. Cost of illness pasien stroke. J Manag Pharm Pract. 2015;5(2):95–103.
5. Pinzon Mkes dr R, Asanti SpS dr LA. Awas stroke! Pengertian, Gejala, Tindakan, Perawatan dan Pencegahan. Penerbit Andi; 2010. 84 p.
6. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011 May;42(2):517–84.
7. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. 27(13):1610–9.
8. Permenkes. PERMENKES Nomor 76 Tahun 2016 Tentang Pedoman INACBG Dalam Pelaksanaan JKN. 2016.
9. Heeley E, Anderson CS, Huang Y, Jan S, Li Y, Liu M, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009;40(6):2149–56.
10. van Eeden M, van Heugten C, van Mastrigt G, van Mierlo M, Visser-Meily JMA, Evers S. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ Open. 2015 Mar;5(11):e008220.
11. Wu Y, Zheng H, Hu S, Chen X, Chen Y, Liu J, et al. The impact of metabolic diseases and their comorbidities for stroke in a middle-income area of China: a case-control study. Int J Neurosci. 2022 Apr;133(9):1055–63.
12. Hum B, Taneja K, Bunachita S, Ashor H, Shin J, Bright A, et al. Unveiling the evolving landscape of stroke care costs: A time-driven analysis. J Stroke Cerebrovasc Dis. 2024 Apr;33(6):107663.
13. Lv W, Wang A, Wang Q, Wang R, Xu Q, Wu S, et al. One-year direct and indirect costs of ischaemic stroke in China. Stroke Vasc Neurol. 2023 Apr;svn-2023.
14. Sidelnikov E, Dornstauder E, Jacob C, Maas C, Pinto L, Leidl R, et al. Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany – results of a claims database study. J Med Econ. 2022 Apr;25(1):1199–206.
15. Cheon S, Li CY, Jeng JS, Wang JD, Ku LJE. The lifetime burden following stroke: Long term impact of stroke on survival and quality of life. Int J Stroke. 2023 Apr;18(7):795–803.
16. Billioti de Gage S, Bertrand M, Grimaldi S, Zureik M. Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab: A Nationwide Cohort Study. Ophthalmol Ther. 2022 Apr;11(2):587–602.
17. Lucas-Noll J, Clua-Espuny JL, Lleixà-Fortuño M, Gavaldà-Espelta E, Queralt-Tomas L, Panisello-Tafalla A, et al. The costs associated with stroke care continuum: a systematic review. Health Econ Rev. 2023;13(1):1–18.
18. Noto S, Murata T, Saito S, Watanabe T, Kobayashi M. Preferences for Rehabilitation in Persons with a History of Stroke: A Discrete Choice Experiment. Patient Prefer Adherence. 2023 Apr;17:1611–20.
19. Zhi M, Hu L, Geng F, Shao N, Liu Y. Analysis of the Cost and Case-mix of Post-acute Stroke Patients in China Using Quantile Regression and the Decision-tree Models. Risk Manag Healthc Policy. 2022 Apr;15:1113–27.
20. Wirbka L, Ruff C, Haefeli WE, Meid AD. A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation. J Manag Care Spec Pharm. 2022 Apr;28(10):10.18553/jmcp.2022.28.10.1161.
21. Wenger NK, Lloyd-Jones DM, Elkind MS V, Fonarow GC, Warner JJ, Alger HM, et al. Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association. Circulation. 2022 Apr;145(23):e1059–71.
22. Chen R, Zhang S, Li J, Guo D, Zhang W, Wang X, et al. A study on predicting the length of hospital stay for Chinese patients with ischemic stroke based on the XGBoost algorithm. BMC Med Inform Decis Mak. 2023 Apr;23(1):49.
23. Ferreira NC, Luvizutto GJ, Bazan SGZ, Bonome LAM, Winckler FC, dos Santos DFB, et al. Challenges in adapting a stroke unit in a middle-income country: warning about costs and underfunding to achieve the Brazilian Ministry of Health’s benchmark. Front Public Heal. 2024 Apr;12:1264292.
24. Abrignani MG, Lombardo A, Braschi A, Renda N, Abrignani V, Lombardo RM. Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation. World J Cardiol. 2022 Apr;14(11):576–98.
25. Kumluang S, Wu O, Langhorne P, Geue C. Stroke resource utilisation and all-cause mortality in Thailand 2017–2020: A retrospective, cross-sectional study. BMJ Open. 2023 Apr;13(6):e072259.
26. Kim J, Grimley R, Kilkenny MF, Cadigan G, Johnston T, Andrew NE, et al. Costs of acute hospitalisation for stroke and transient ischaemic attack in Australia. Heal Inf Manag J. 2022 Apr;52(3):176–84.
27. Cygańska M, Kludacz-Alessandri M, Pyke C. Healthcare Costs and Health Status: Insights from the SHARE Survey. Int J Environ Res Public Health. 2023 Apr;20(2):1418.
28. Pohan VY, Yanto A, Pranata S. Correlation of the Caring Behaviour of Nurses With the Motivation of Patients Undergoing Haemodialysis. 2024;
29. Chanif C, Nursalam N, Sriyono S, Yuniasari L, Pranata S, Armiyati Y. The Correlation Between Nurses’ Knowledge of Triage and the Accuracy of Triage Level Interpretation in the Emergency Department. Scr Medica (Banja Luka). 2023;54(4):385–8.
30. Joan Imanuella Hanna Pangaemanan. Perbedaan BPJS kelas 1,2,3 dan cara pindah kelas.
https://mediaindonesia.com/humaniora/632187/. 2023. p. https://mediaindonesia.com/humaniora/632187/perbed.
31. Nisa. Perbedaan Faskes BPJS Tingkat 1, 2, 3 yang Harus Diketahui. metro news. 2023.